ASCO 2019: Post-Hoc Analysis of Carmena Confirms Targeted Therapy as Gold Standard for Metastatic Renal Cell Cancer
Study presenter highlights that cytoreductive nephrectomy has a role to play nevertheless
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.